A Novel APJ Receptor Agonist for Repair of Vascular Damage and Lung Fibrosis in Scleroderma/Systemic Sclerosis
NCBiotech Grants & Loans
See the full listing of all NCBiotech grants and loans awarded since July 2012.
Organization
Apie Therapeutics, Inc.
Award Date
Award Amount
250,000
Program Name
Small Business Research Loan
Program Category
Business Financing
Principal Investigator
Esther Alegria
Fiscal Year
2022
Region
Research Triangle
Project Description:
APIE Therapeutics is developing anti-fibrotic therapeutics to treat chronic diseases including Scleroderma, a disabling automimmune disorder resulting in vascular damage and fibrotic scarring in organ systems. The company was awarded $250,000 in SRL funding to perform GLP Genetic Toxicology studies and to prepare for their Pre-IND FDA meeting.